If you’re struggling with obesity and considering Wegovy as a treatment option, you might be wondering if Medicare will cover the cost. The answer isn’t straightforward, as Medicare coverage for weight loss medications like Wegovy has been limited in the past. However, recent developments have opened the door for potential coverage, giving hope to millions of Medicare beneficiaries who could benefit from this groundbreaking drug. Keep reading to learn more.
What is Wegovy?
Wegovy is a brand-name prescription medication used for chronic weight management in adults who are obese or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. It’s a once-weekly injectable drug and is classified as a GLP-1 receptor agonist. These drugs work by mimicking the effects of a hormone called glucagon-like peptide-1, which helps regulate appetite and metabolism.
Wegovy has been shown to be highly effective in clinical trials, with participants losing an average of 15% of their body weight over 68 weeks. If you’re considering Wegovy, it’s important to talk to your healthcare provider about the potential benefits and risks, as well as the cost and coverage options available to you.
Medicare Coverage for Wegovy
Traditionally, Medicare has been prohibited by law from covering weight loss medications like Wegovy when used specifically for obesity. However, a recent FDA decision has opened the door to potential coverage. In 2023, the FDA approved a new use for Wegovy to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese. This new indication means that Medicare Part D plans can now add Wegovy to their formularies, as it’s no longer considered a drug used solely for weight loss.
If you have Medicare Part D prescription drug coverage, either through a standalone plan or a Medicare Advantage plan that includes drug coverage, your plan may choose to cover Wegovy. However, coverage isn’t guaranteed, as plans can decide which drugs to include on their formularies. You’ll need to check with your specific plan to see if Wegovy is covered and what your out-of-pocket costs might be.
It’s important to note that even if your Medicare plan covers Wegovy, you may still face significant out-of-pocket costs. Based on the list price of $1,300 per month, Wegovy could be placed on a specialty tier, where you’d be responsible for paying coinsurance of 25% to 33%. This means you could pay hundreds of dollars per month until you reach your plan’s annual out-of-pocket spending cap.
Potential Impact on Medicare Beneficiaries
With the FDA’s approval of a new use for Wegovy, millions of Medicare beneficiaries could potentially benefit from this innovative weight loss medication. According to a recent analysis by the Kaiser Family Foundation, an estimated 3.6 million Medicare beneficiaries, or about 7% of the total Medicare population, had established cardiovascular disease and were either overweight or obese in 2020. This means that roughly 1 in 4 Medicare beneficiaries who are overweight or obese might be eligible to receive coverage for Wegovy.
However, not all of these eligible beneficiaries will necessarily take Wegovy, even if their Medicare plan covers it. Some may be hesitant to try the medication due to potential side effects or adverse reactions, while others may find the out-of-pocket costs too burdensome, even with Medicare coverage. Based on the list price of $1,300 per month, beneficiaries could face monthly costs of $325 to $430 in coinsurance alone, which could be a significant financial barrier for many.
Additionally, Medicare plans may impose coverage restrictions, such as prior authorization or step therapy, which could limit access to Wegovy for some beneficiaries. These tools are used by plans to manage costs and ensure appropriate use of medications, but they can also create additional hurdles for beneficiaries seeking treatment.
Despite these challenges, the potential impact of Wegovy’s new indication on Medicare beneficiaries shouldn’t be overlooked. If you’re able to access and afford the medication, Wegovy could provide a valuable tool for managing obesity and reducing the risk of serious cardiovascular events.
Limitations and Exclusions
The new indication for Wegovy is specifically for people with established cardiovascular disease who are overweight or obese. If you don’t have a history of heart attack, stroke, or peripheral arterial disease, you may not be eligible for coverage under this new indication. However, if you have diabetes (other than Type 1) and are overweight or obese, you may already be eligible for coverage of GLP-1 receptor agonists like Wegovy as diabetes treatments.
Even if you meet the criteria for the new indication, your Medicare plan may still impose restrictions on coverage. For example, your plan may require prior authorization, meaning your healthcare provider will need to provide documentation to justify the medical necessity of Wegovy for your specific situation. Your plan may also use step therapy, requiring you to try other, less expensive weight loss treatments before covering Wegovy.
Lastly, not everyone who is eligible for Wegovy under the new indication will necessarily benefit from the drug. Some people may experience side effects or adverse reactions that make the medication unsuitable for them. Others may find the out-of-pocket costs prohibitive, even with Medicare coverage.
Conclusion
As you consider your options for managing obesity and reducing your risk of serious cardiovascular events, it’s important to understand the potential role of Wegovy and how Medicare coverage for this medication is evolving. The FDA’s approval of a new use for Wegovy has opened the door to Medicare coverage for millions of beneficiaries who could benefit from this innovative treatment.
Just keep in mind that coverage isn’t guaranteed. Even if your Medicare plan does cover Wegovy, you may face significant out-of-pocket costs or coverage restrictions. It’s essential to have an open and honest conversation with your healthcare provider about whether Wegovy is right for you, taking into account your individual health needs, potential side effects, and financial situation.
For more information about Medicare coverage for Wegovy, please call 866-633-4427 to speak with a Senior Healthcare Solutions Medicare expert. Our knowledgeable team is here to answer your questions and help you understand your coverage options. We can also review your Medicare plan to determine if Wegovy is covered and help you understand any out-of-pocket costs or coverage restrictions that may apply.
